share_log

Obesity In Children - US Parents Face Tough Time To Access Recommended Treatment, Though Novo Nordisk's Drug Still Sees Strong Demand

Obesity In Children - US Parents Face Tough Time To Access Recommended Treatment, Though Novo Nordisk's Drug Still Sees Strong Demand

兒童肥胖症-美國家長很難獲得推薦的治療,儘管諾和諾德的藥物仍然有強烈的需求
Benzinga ·  00:30

Many U.S. parents seeking help for their child with obesity face challenges accessing the recommended treatment. Leading medical groups advocate for intensive behavioral counseling, requiring 26 hours within a year to teach healthier eating and activity habits.

許多美國父母在尋求幫助孩子減肥方面面臨着困難,著名醫療機構主張進行強化行爲諮詢,每年需提供26個小時的健康飲食和運動方面的培訓來幫助孩子建立健康的飲食和運動習慣。

Also Read: Novo Nordisk Sues Additional US Clinics Against Fake Semaglutide Products Used For Weight Loss, Diabetes.

還閱讀:諾和諾德起訴更多美國診所售假減肥、糖尿病藥物semaglutide。

However, as numerous doctors and parents have noted, these programs are often unavailable, have long waitlists, are not covered by insurance, and require significant time commitments.

然而,正如許多醫生和父母指出的那樣,這些計劃通常無法提供,等待名單長,不被保險業覆蓋,並需要大量時間。

The U.S. Centers for Disease Control and Prevention (CDC) revealed that fewer than 1% of the nearly 15 million children with obesity receive such structured care, Reuters reported.

消息人士向路透社披露,美國疾病控制和預防中心(CDC)透露,近1500萬患有肥胖症的兒童中,不到1%的人接受到這樣的結構化保健。

Efforts to expand insurance coverage have stalled. "The coverage for these programs was never good, and we're not seeing any movement toward improvement," said Dr. Joseph Skelton, a professor of pediatrics at Wake Forest University School of Medicine.

擴大保險覆蓋範圍的努力已經停滯不前。 維克森林大學醫學院的兒科教授約瑟夫·斯凱爾頓博士說:“這些計劃的保險覆蓋從未很好,我們尚未看到任何改善的跡象。”

Obesity rates among U.S. children have climbed from 5% in 1980 to nearly 20% today, the report noted, citing CDC data.

據CDC數據顯示,美國兒童的肥胖率從1980年的5%上升到了近20%。

While Novo Nordisk A/S's (NYSE:NVO) Wegovy offers an effective weight-loss solution for adults and adolescents, there is concern about its long-term effects on children's development.

諾和諾德公司(NYSE:NVO)的Wegovy提供了一種有效的減重方案,面向成人和青少年,但有人對它對兒童發育的長期影響表示擔憂。

Despite these concerns, demand for Wegovy remains high, with at least 25,000 first-time prescriptions dispensed weekly to adults.

儘管存在這些問題,Wegovy的需求仍然很高,每週至少有25,000份首次處方被髮放給成年人。

Changing habits instead of medication is the preferred approach for some families. The report cited Medina's 15-year-old daughter, Jelainie, who enrolled in a healthy weight program at Holyoke Health Center. However, the program has a four-month waitlist, and state Medicaid partially covers participation.

改變飲食習慣而不是藥物治療是一些家庭的首選方法。報告援引Medina的15歲女兒Jelainie的話稱,她加入了Holyoke Health Center的健康體重計劃。但是,該計劃有四個月的等待名單,且州屬醫療補助只部分覆蓋參加費用。

At Stanford Medicine Children's Health, Dr. Thomas Robinson emphasized that reliance solely on drugs could lead to nutritional deficiencies or eating disorders.

在斯坦福醫學兒童健康中心,Thomas Robinson博士強調,僅依賴藥物可能會導致營養不良或進食障礙。

The report further noted that Stanford's program teaches families to categorize foods into "red-light" (to be eaten sparingly), "yellow-light," and "green-light" (to be consumed freely) foods, though it costs $3,500 and is not covered by insurance.

報告進一步指出,斯坦福的計劃將食物分爲“紅燈”(應少吃),“黃燈”和“綠燈”(可以自由食用),但該計劃需要花費3500美元,且不在保險覆蓋範圍內。

Efforts to improve insurance coverage for obesity counseling face hurdles. The American Medical Association (AMA) recently rejected a request for a dedicated medical code for the 26-hour counseling program, which would help providers bill for services, per the report.

爲肥胖諮詢改善保險覆蓋範圍的努力面臨困難。 美國醫學協會(AMA)最近拒絕了一項請求,該請求是爲26小時輔導計劃創建一個專用的醫療代碼,以幫助提供者計費,根據報告顯示。

The CDC stressed the need for equitable access to both obesity medications and lifestyle treatments to support children's health.

美國疾控中心強調,有必要公平獲取肥胖症藥物和生活方式治療,以支持兒童的健康。

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

免責聲明本內容部分由人工智能工具生成,並經Benzinga編輯審核和發佈。

Photo via Shutterstock

圖片來自shutterstock。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論